Your session is about to expire
← Back to Search
Procedure
Epidural Stimulation + Training for Spinal Cord Injury (MC-PP-3 Trial)
N/A
Recruiting
Research Sponsored by Susan Harkema PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
unable to voluntarily move all individual joints of the legs
Bladder dysfunction as a result of SCI
Must not have
Cardiovascular, respiratory, bladder, or renal disease unrelated to SCI
Ventilator dependent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 80 sessions, approximately 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether epidural stimulation can help people with spinal cord injuries walk and improve their bladder function.
Who is the study for?
This trial is for adults over 18 with a stable, non-progressive spinal cord injury (SCI) between T1 and T10. They must be within one year post-injury, unable to stand or walk independently, have bladder dysfunction due to SCI, and not on anti-spasticity meds or received botox in the last six months. Excluded are those ventilator-dependent, with untreated major health issues or psychiatric disorders/drug abuse.
What is being tested?
The study tests if epidural stimulation can improve standing, walking, and bladder functions in people with acute SCI. Participants will undergo different training protocols: Bladder Capacity Training, Bladder Voiding Efficiency Training, Step Training or Stand Training alongside the epidural stimulation.
What are the potential side effects?
While specific side effects aren't listed here for this intervention type; generally speaking such procedures may cause discomfort at the stimulation site, potential infection risk from surgery and possible nerve irritation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I cannot move all the joints in my legs on my own.
Select...
I have bladder problems due to a spinal cord injury.
Select...
I am not taking any medication for muscle stiffness.
Select...
I cannot move all the joints in my legs on my own.
Select...
My spinal cord injury is between the T1 and T10 vertebrae.
Select...
I cannot stand or walk on my own.
Select...
I am not currently taking any medication for muscle stiffness.
Select...
My spinal cord injury is not getting worse.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have heart, lung, bladder, or kidney conditions not caused by my spinal cord injury.
Select...
I rely on a machine to help me breathe.
Select...
I have untreated painful bone or muscle issues, fractures, or pressure sores.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 80 sessions, approximately 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~80 sessions, approximately 3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Ambulation
Bladder storage/voiding
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: LocomotionExperimental Treatment2 Interventions
Participants will receive 160 locomotor training sessions with epidural stimulation. These sessions may occur once a day (stand and step will alternate days) or twice a day (stand and step on the same day) as recommended by the study physician. Participants will train 5 days per week and each session will last between 1 to 1.5 hours.
Group II: Bladder+LocomotionExperimental Treatment4 Interventions
Participants will receive 80 sessions of bladder training alone followed by 80 sessions of locomotor training sessions with epidural stimulation. They will be asked to continue with your bladder training once you start locomotor training. Locomotor Training sessions may occur once a day (stand and step will alternate days) or twice a day (stand and step on the same day) as recommended by the study physician. Participants will train 5 days per week and each session will last between 1 to 1.5 hours.
Find a Location
Who is running the clinical trial?
Susan Harkema PhDLead Sponsor
1 Previous Clinical Trials
16 Total Patients Enrolled
University of LouisvilleLead Sponsor
348 Previous Clinical Trials
77,362 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,383 Previous Clinical Trials
652,538 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot move all the joints in my legs on my own.Your injury occurred no more than 1 year ago.I have not had any botox injections in the last six months.I have bladder problems due to a spinal cord injury.I am not taking any medication for muscle stiffness.I have heart, lung, bladder, or kidney conditions not caused by my spinal cord injury.I cannot move all the joints in my legs on my own.My spinal cord injury is between the T1 and T10 vertebrae.I cannot stand or walk on my own.I am not currently taking any medication for muscle stiffness.Your spinal cord injury is not getting worse.My spinal cord injury is not getting worse.My health condition is stable.I rely on a machine to help me breathe.I have untreated painful bone or muscle issues, fractures, or pressure sores.You have a mental health condition that has not been treated, or you are currently abusing drugs.I am 18 years old or older.My health condition is currently stable.
Research Study Groups:
This trial has the following groups:- Group 1: Locomotion
- Group 2: Bladder+Locomotion
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Spinal Cord Injury Patient Testimony for trial: Trial Name: NCT04879862 — N/A